WHWK
NASDAQ · Biotechnology
Whitehawk Therapeutics Inc
$3.76
+0.02 (+0.53%)
Open$3.74
Previous Close$3.74
Day High$3.80
Day Low$3.68
52W High$5.50
52W Low$1.82
Volume—
Avg Volume389.8K
Market Cap213.58M
P/E Ratio—
EPS$-3.03
SectorBiotechnology
Analyst Ratings
Buy
14 analysts
Price Target
+360.4% upside
Current
$3.76
$3.76
Target
$17.31
$17.31
$14.24
$17.31 avg
$28.90
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 8.48M | 10.91M | 8.91M |
| Net Income | -24,428,016 | -28,287,717 | 2.41M |
| Profit Margin | -288.3% | -273.9% | 27.1% |
| EBITDA | -32,087,980 | -39,222,312 | 4.31M |
| Free Cash Flow | — | — | 1.46M |
| Rev Growth | -22.3% | -22.3% | +22.0% |
| Debt/Equity | — | — | 0.54 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $266.28 | +0.73% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $418.13 | +0.85% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $152.21 | +0.85% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $527.67 | +0.28% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $752.25 | -4.54% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $255.36 | -0.23% | 41.4 | 33.44B |